<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on September 20, 2023</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/ct2/show/NCT03268915</url>
  </required_header>
  <id_info>
    <org_study_id>EssaisCliniques_TCL3-FPI</org_study_id>
    <nct_id>NCT03268915</nct_id>
  </id_info>
  <brief_title>Idiopathic Pulmonary Fibrosis (IPF) and the 3 Minutes Sit-to-stand Test</brief_title>
  <acronym>ST2-IPF</acronym>
  <official_title>Assessment of the Reproducibility of the 3 Minutes Sit-to-stand Test in Patients With Idiopathic Pulmonary Fibrosis (IPF)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Grenoble</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Grenoble</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study is designed to evaluate the reproductibility and the performance of the 3 minutes&#xD;
      sit-to-stand test in patients with idiopathic pulmonary fibrosis.&#xD;
&#xD;
      To do this, the investigators are recruiting 40 patients with idiopathic pulmonary fibrosis&#xD;
      in 2 centers (Grenoble university hospital and Lyon university hospital).&#xD;
&#xD;
      Patients had to achieve an effort test on a cycle ergometer. 2 visits are planned in the&#xD;
      hospital. During each visit, patients will perform a 3 minutes sit-to-stand test, a 1 minute&#xD;
      sit-to-stand test and a 6 minutes walk test. During the second visit, patients will also&#xD;
      perform a 3 minutes sit-to-stand test with measurement of oxygen uptake.&#xD;
&#xD;
      The investigators will then analyse the results by comparing numbers of cycle, functional&#xD;
      response and symptoms during the 3 minutes sit-to-stand test of the 2 visits. The&#xD;
      investigators will also compare the functional response obtained during the 3 minutes&#xD;
      sit-to-stand test, the 1 minute sit-to-stand test and the 6 minutes walk test.&#xD;
&#xD;
      Finally, the investigators will compare the maximal values of oxygen uptake, respiration rate&#xD;
      and expired volume obtained during the 3 minutes sit-to-stand test to the effort test on&#xD;
      cycle ergometer.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">February 9, 2017</start_date>
  <completion_date type="Actual">December 9, 2018</completion_date>
  <primary_completion_date type="Actual">December 9, 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <intervention_model_description>The investigators want to test the reproductibility of a 3 minutes sit-to-stand test in patients with idiopathic pulmonary fibrosis.&#xD;
For this, patient perform the test during 2 visits and the investigators are going to compare the results of the two visits.</intervention_model_description>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Reproductibility of the 3 minutes sit-to-stand test in patient with idiopathic pulmonary fibrosis</measure>
    <time_frame>2 days</time_frame>
    <description>Evaluate the reproductibility for the number of rise and down during the 3 minutes sit-to-stand test of the 2 visits (the investigators will compare the number of rise and sit during the 3 minutes sit-to-stand test of the 2 visits to see if they are similar)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Functional response during the 3 minutes sit-to-stand test: Oxygen saturation</measure>
    <time_frame>2 days</time_frame>
    <description>Evaluate the reproductibility of functional response (oxygen saturation) during the 3 minutes sit-to-stand test</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>3 minutes sit-to-stand test compared to the 6 minutes walk test: oxygen saturation</measure>
    <time_frame>2 days</time_frame>
    <description>compared oxygen saturation during the 3 minutes sit-to-stand test to the 6 minutes walk test</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>1 minute sit-to-stand test compared to 3 minutes sit-to-stand: oxygen saturation</measure>
    <time_frame>2 days</time_frame>
    <description>Compared oxygen saturation during the 3 minutes sit-to-stand test with 1 minute sit-to-stand test</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Functional response during the 3 minutes sit-to-stand test: Heart rate</measure>
    <time_frame>2 days</time_frame>
    <description>Evaluate the reproductibility of functional response (heart rate) during the 3 minutes sit-to-stand test</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Functional response during the 3 minutes sit-to-stand test: symptoms</measure>
    <time_frame>2 days</time_frame>
    <description>Evaluate the reproductibility of functional response (symptoms) during the 3 minutes sit-to-stand test</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>3 minutes sit-to-stand test compared to the 6 minutes walk test: heart rate</measure>
    <time_frame>2 days</time_frame>
    <description>Compared heart rate during the 3 minutes sit-to-stand test to the 6 minutes walk test</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>3 minutes sit-to-stand test compared to the 6 minutes walk test: symptoms</measure>
    <time_frame>2 days</time_frame>
    <description>Compared symptoms during the 3 minutes sit-to-stand test to the 6 minutes walk test</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>1 minute sit-to-stand test compared to 3 minutes sit-to-stand: heart rate</measure>
    <time_frame>2 days</time_frame>
    <description>Compared heart rate during the 3 minutes sit-to-stand test with 1 minute sit-to-stand test</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>1 minute sit-to-stand test compared to 3 minutes sit-to-stand: symptoms</measure>
    <time_frame>2 days</time_frame>
    <description>Compared symptoms during the 3 minutes sit-to-stand test with 1 minute sit-to-stand test</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">35</enrollment>
  <condition>Idiopathic Pulmonary Fibrosis</condition>
  <arm_group>
    <arm_group_label>patient with idiopathic pulmonary fibrosis</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>3 minutes sit-to-stand test</intervention_name>
    <description>3 minutes sit-to-stand test, 1 minute sit-to-stand test, 6 minutes walk test will be performed 2 times for each patients 3 minutes sit-to-stand test with oxygen uptake measurement will be performed one time for each patient</description>
    <arm_group_label>patient with idiopathic pulmonary fibrosis</arm_group_label>
    <other_name>6 minutes walk test</other_name>
    <other_name>1 minute sit-to-stand test</other_name>
    <other_name>3 minutes sit-to-stand test with oxygen uptake measurement</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  man or woman aged less than 85 years&#xD;
&#xD;
          -  patients with Idiopathic Pulmonary Fibrosis without any acute exacerbation during 4&#xD;
             months before the inclusion&#xD;
&#xD;
          -  Non-opposition to participation in research&#xD;
&#xD;
          -  Patient with 6 minutes walk test &gt; 200 meters (with or without oxygen therapy)&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patient with reduced locomotor activity, or joint pain that compromises the&#xD;
             performance of the tests&#xD;
&#xD;
          -  Patient with 6 minutes walk test &lt; 200 meters&#xD;
&#xD;
          -  Patient with an other etiology of pulmonary fibrosis&#xD;
&#xD;
          -  Other significant pulmonary diseases&#xD;
&#xD;
          -  Patient with unstable cardiac disease&#xD;
&#xD;
          -  Patient who may be, according to the investigator's assessment, not cooperating or&#xD;
             respecting the obligations inherent in participating to the study.&#xD;
&#xD;
          -  Opposition to participation in research&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>CHU Grenoble Alpes</name>
      <address>
        <city>La Tronche</city>
        <zip>38700</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Groupement Hospitalier Est</name>
      <address>
        <city>Lyon</city>
        <zip>69677</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <results_reference>
    <citation>King TE Jr, Pardo A, Selman M. Idiopathic pulmonary fibrosis. Lancet. 2011 Dec 3;378(9807):1949-61. doi: 10.1016/S0140-6736(11)60052-4. Epub 2011 Jun 28.</citation>
    <PMID>21719092</PMID>
  </results_reference>
  <results_reference>
    <citation>Cottin V, Crestani B, Valeyre D, Wallaert B, Cadranel J, Dalphin JC, Delaval P, Israel-Biet D, Kessler R, Reynaud-Gaubert M, Cordier JF, Aguilaniu B, Bouquillon B, Carre P, Danel C, Faivre JB, Ferreti G, Just N, Kouzan S, Lebargy F, Marchand Adam S, Philippe B, Prevot G, Stach B, Thivolet-Bejui F; French National Reference and Competence Centers for Rare Diseases; Societe de Pneumologies de Langue Francaise. [French practical guidelines for the diagnosis and management of idiopathic pulmonary fibrosis. From the National Reference and the Competence centers for rare diseases and the Societe de Pneumologie de Langue Francaise]. Rev Mal Respir. 2013 Dec;30(10):879-902. doi: 10.1016/j.rmr.2013.09.007. Epub 2013 Oct 25. No abstract available. Erratum In: Rev Mal Respir. 2014 Feb;31(2):194-5. French.</citation>
    <PMID>24314711</PMID>
  </results_reference>
  <results_reference>
    <citation>Raghu G, Collard HR, Egan JJ, Martinez FJ, Behr J, Brown KK, Colby TV, Cordier JF, Flaherty KR, Lasky JA, Lynch DA, Ryu JH, Swigris JJ, Wells AU, Ancochea J, Bouros D, Carvalho C, Costabel U, Ebina M, Hansell DM, Johkoh T, Kim DS, King TE Jr, Kondoh Y, Myers J, Muller NL, Nicholson AG, Richeldi L, Selman M, Dudden RF, Griss BS, Protzko SL, Schunemann HJ; ATS/ERS/JRS/ALAT Committee on Idiopathic Pulmonary Fibrosis. An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. Am J Respir Crit Care Med. 2011 Mar 15;183(6):788-824. doi: 10.1164/rccm.2009-040GL.</citation>
    <PMID>21471066</PMID>
  </results_reference>
  <results_reference>
    <citation>Nalysnyk L, Cid-Ruzafa J, Rotella P, Esser D. Incidence and prevalence of idiopathic pulmonary fibrosis: review of the literature. Eur Respir Rev. 2012 Dec 1;21(126):355-61. doi: 10.1183/09059180.00002512.</citation>
    <PMID>23204124</PMID>
  </results_reference>
  <results_reference>
    <citation>Huang XF, Gao F, Xue ZQ, Wang Y, Xu GW. [Multifactorial analysis of survival in breast cancer]. Zhonghua Zhong Liu Za Zhi. 1988 Mar;10(2):117-9. Chinese.</citation>
    <PMID>3208648</PMID>
  </results_reference>
  <results_reference>
    <citation>du Bois RM, Weycker D, Albera C, Bradford WZ, Costabel U, Kartashov A, Lancaster L, Noble PW, Sahn SA, Szwarcberg J, Thomeer M, Valeyre D, King TE Jr. Six-minute-walk test in idiopathic pulmonary fibrosis: test validation and minimal clinically important difference. Am J Respir Crit Care Med. 2011 May 1;183(9):1231-7. doi: 10.1164/rccm.201007-1179OC. Epub 2010 Dec 3.</citation>
    <PMID>21131468</PMID>
  </results_reference>
  <results_reference>
    <citation>Nathan SD, du Bois RM, Albera C, Bradford WZ, Costabel U, Kartashov A, Noble PW, Sahn SA, Valeyre D, Weycker D, King TE Jr. Validation of test performance characteristics and minimal clinically important difference of the 6-minute walk test in patients with idiopathic pulmonary fibrosis. Respir Med. 2015 Jul;109(7):914-22. doi: 10.1016/j.rmed.2015.04.008. Epub 2015 Apr 24.</citation>
    <PMID>25956020</PMID>
  </results_reference>
  <results_reference>
    <citation>ATS Committee on Proficiency Standards for Clinical Pulmonary Function Laboratories. ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med. 2002 Jul 1;166(1):111-7. doi: 10.1164/ajrccm.166.1.at1102. No abstract available. Erratum In: Am J Respir Crit Care Med. 2016 May 15;193(10):1185.</citation>
    <PMID>12091180</PMID>
  </results_reference>
  <results_reference>
    <citation>Jones CJ, Rikli RE, Beam WC. A 30-s chair-stand test as a measure of lower body strength in community-residing older adults. Res Q Exerc Sport. 1999 Jun;70(2):113-9. doi: 10.1080/02701367.1999.10608028.</citation>
    <PMID>10380242</PMID>
  </results_reference>
  <results_reference>
    <citation>Buatois S, Miljkovic D, Manckoundia P, Gueguen R, Miget P, Vancon G, Perrin P, Benetos A. Five times sit to stand test is a predictor of recurrent falls in healthy community-living subjects aged 65 and older. J Am Geriatr Soc. 2008 Aug;56(8):1575-7. doi: 10.1111/j.1532-5415.2008.01777.x. No abstract available.</citation>
    <PMID>18808608</PMID>
  </results_reference>
  <results_reference>
    <citation>Macfarlane DJ, Chou KL, Cheng YH, Chi I. Validity and normative data for thirty-second chair stand test in elderly community-dwelling Hong Kong Chinese. Am J Hum Biol. 2006 May-Jun;18(3):418-21. doi: 10.1002/ajhb.20503.</citation>
    <PMID>16634026</PMID>
  </results_reference>
  <results_reference>
    <citation>Hill CJ, Denehy L, Holland AE, McDonald CF. Measurement of functional activity in chronic obstructive pulmonary disease: the grocery shelving task. J Cardiopulm Rehabil Prev. 2008 Nov-Dec;28(6):402-9. doi: 10.1097/HCR.0b013e31818c3c65.</citation>
    <PMID>19008696</PMID>
  </results_reference>
  <results_reference>
    <citation>Perrault H, Baril J, Henophy S, Rycroft A, Bourbeau J, Maltais F. Paced-walk and step tests to assess exertional dyspnea in COPD. COPD. 2009 Oct;6(5):330-9. doi: 10.1080/15412550903156317.</citation>
    <PMID>19863362</PMID>
  </results_reference>
  <results_reference>
    <citation>Brodin E, Ljungman S, Sunnerhagen KS. Rising from a chair: a simple screening test for physical function in predialysis patients. Scand J Urol Nephrol. 2008;42(3):293-300. doi: 10.1080/00365590701797556.</citation>
    <PMID>18432536</PMID>
  </results_reference>
  <results_reference>
    <citation>Ozalevli S, Ozden A, Itil O, Akkoclu A. Comparison of the Sit-to-Stand Test with 6 min walk test in patients with chronic obstructive pulmonary disease. Respir Med. 2007 Feb;101(2):286-93. doi: 10.1016/j.rmed.2006.05.007. Epub 2006 Jun 27.</citation>
    <PMID>16806873</PMID>
  </results_reference>
  <results_reference>
    <citation>Craig CP, Reynolds SL, Airhart JW, Staab EV. Alterations in immune responses by attenuated Venezuelan equine encephalitis vaccine. I. Adjuvant effect of VEE virus infection in guinea pigs. J Immunol. 1969 May;102(5):1220-7. No abstract available.</citation>
    <PMID>4181548</PMID>
  </results_reference>
  <results_reference>
    <citation>Bland JM, Altman DG. Measuring agreement in method comparison studies. Stat Methods Med Res. 1999 Jun;8(2):135-60. doi: 10.1177/096228029900800204.</citation>
    <PMID>10501650</PMID>
  </results_reference>
  <results_reference>
    <citation>Passing H, Bablok. A new biometrical procedure for testing the equality of measurements from two different analytical methods. Application of linear regression procedures for method comparison studies in clinical chemistry, Part I. J Clin Chem Clin Biochem. 1983 Nov;21(11):709-20. doi: 10.1515/cclm.1983.21.11.709.</citation>
    <PMID>6655447</PMID>
  </results_reference>
  <results_reference>
    <citation>Carstensen B. Comparing methods of measurement: Extending the LoA by regression. Stat Med. 2010 Feb 10;29(3):401-10. doi: 10.1002/sim.3769.</citation>
    <PMID>19998394</PMID>
  </results_reference>
  <verification_date>August 2019</verification_date>
  <study_first_submitted>July 21, 2017</study_first_submitted>
  <study_first_submitted_qc>August 28, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">August 31, 2017</study_first_posted>
  <last_update_submitted>August 7, 2019</last_update_submitted>
  <last_update_submitted_qc>August 7, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">August 8, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Idiopathic pulmonary fibrosis</keyword>
  <keyword>3 minutes sit-to-stand test</keyword>
  <keyword>Interindividual reproductibility</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pulmonary Fibrosis</mesh_term>
    <mesh_term>Idiopathic Pulmonary Fibrosis</mesh_term>
    <mesh_term>Fibrosis</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>


download date: ClinicalTrials.gov processed this data on September 20, 2023
link text: Link to the current ClinicalTrials.gov record.
url: https://clinicaltrials.gov/ct2/show/NCT03268915
org study id: EssaisCliniques_TCL3-FPI
nct id: NCT03268915
lead sponsor: 
has dmc: Yes
is fda regulated drug: No
is fda regulated device: No
This study is designed to evaluate the reproductibility and the performance of the 3 minutes
      sit-to-stand test in patients with idiopathic pulmonary fibrosis.

      To do this, the investigators are recruiting 40 patients with idiopathic pulmonary fibrosis
      in 2 centers (Grenoble university hospital and Lyon university hospital).

      Patients had to achieve an effort test on a cycle ergometer. 2 visits are planned in the
      hospital. During each visit, patients will perform a 3 minutes sit-to-stand test, a 1 minute
      sit-to-stand test and a 6 minutes walk test. During the second visit, patients will also
      perform a 3 minutes sit-to-stand test with measurement of oxygen uptake.

      The investigators will then analyse the results by comparing numbers of cycle, functional
      response and symptoms during the 3 minutes sit-to-stand test of the 2 visits. The
      investigators will also compare the functional response obtained during the 3 minutes
      sit-to-stand test, the 1 minute sit-to-stand test and the 6 minutes walk test.

      Finally, the investigators will compare the maximal values of oxygen uptake, respiration rate
      and expired volume obtained during the 3 minutes sit-to-stand test to the effort test on
      cycle ergometer.
allocation: N/A
intervention model: Single Group Assignment
intervention model description: The investigators want to test the reproductibility of a 3 minutes sit-to-stand test in patients with idiopathic pulmonary fibrosis.
For this, patient perform the test during 2 visits and the investigators are going to compare the results of the two visits.
primary purpose: Diagnostic
masking: None (Open Label)
measure: Reproductibility of the 3 minutes sit-to-stand test in patient with idiopathic pulmonary fibrosis
time frame: 2 days
description: Evaluate the reproductibility for the number of rise and down during the 3 minutes sit-to-stand test of the 2 visits (the investigators will compare the number of rise and sit during the 3 minutes sit-to-stand test of the 2 visits to see if they are similar)
measure: Functional response during the 3 minutes sit-to-stand test: Oxygen saturation
time frame: 2 days
description: Evaluate the reproductibility of functional response (oxygen saturation) during the 3 minutes sit-to-stand test
measure: 3 minutes sit-to-stand test compared to the 6 minutes walk test: oxygen saturation
time frame: 2 days
description: compared oxygen saturation during the 3 minutes sit-to-stand test to the 6 minutes walk test
measure: 1 minute sit-to-stand test compared to 3 minutes sit-to-stand: oxygen saturation
time frame: 2 days
description: Compared oxygen saturation during the 3 minutes sit-to-stand test with 1 minute sit-to-stand test
measure: Functional response during the 3 minutes sit-to-stand test: Heart rate
time frame: 2 days
description: Evaluate the reproductibility of functional response (heart rate) during the 3 minutes sit-to-stand test
measure: Functional response during the 3 minutes sit-to-stand test: symptoms
time frame: 2 days
description: Evaluate the reproductibility of functional response (symptoms) during the 3 minutes sit-to-stand test
measure: 3 minutes sit-to-stand test compared to the 6 minutes walk test: heart rate
time frame: 2 days
description: Compared heart rate during the 3 minutes sit-to-stand test to the 6 minutes walk test
measure: 3 minutes sit-to-stand test compared to the 6 minutes walk test: symptoms
time frame: 2 days
description: Compared symptoms during the 3 minutes sit-to-stand test to the 6 minutes walk test
measure: 1 minute sit-to-stand test compared to 3 minutes sit-to-stand: heart rate
time frame: 2 days
description: Compared heart rate during the 3 minutes sit-to-stand test with 1 minute sit-to-stand test
measure: 1 minute sit-to-stand test compared to 3 minutes sit-to-stand: symptoms
time frame: 2 days
description: Compared symptoms during the 3 minutes sit-to-stand test with 1 minute sit-to-stand test
arm group label: patient with idiopathic pulmonary fibrosis
arm group type: Experimental
intervention type: Diagnostic Test
intervention name: 3 minutes sit-to-stand test
description: 3 minutes sit-to-stand test, 1 minute sit-to-stand test, 6 minutes walk test will be performed 2 times for each patients 3 minutes sit-to-stand test with oxygen uptake measurement will be performed one time for each patient
arm group label: patient with idiopathic pulmonary fibrosis
other name: 6 minutes walk test
other name: 1 minute sit-to-stand test
other name: 3 minutes sit-to-stand test with oxygen uptake measurement
criteria: 
gender: All
minimum age: 18 Years
maximum age: 85 Years
healthy volunteers: No
facility: 
facility: 
country: France
citation: King TE Jr, Pardo A, Selman M. Idiopathic pulmonary fibrosis. Lancet. 2011 Dec 3;378(9807):1949-61. doi: 10.1016/S0140-6736(11)60052-4. Epub 2011 Jun 28.
PMID: 21719092
citation: Cottin V, Crestani B, Valeyre D, Wallaert B, Cadranel J, Dalphin JC, Delaval P, Israel-Biet D, Kessler R, Reynaud-Gaubert M, Cordier JF, Aguilaniu B, Bouquillon B, Carre P, Danel C, Faivre JB, Ferreti G, Just N, Kouzan S, Lebargy F, Marchand Adam S, Philippe B, Prevot G, Stach B, Thivolet-Bejui F; French National Reference and Competence Centers for Rare Diseases; Societe de Pneumologies de Langue Francaise. [French practical guidelines for the diagnosis and management of idiopathic pulmonary fibrosis. From the National Reference and the Competence centers for rare diseases and the Societe de Pneumologie de Langue Francaise]. Rev Mal Respir. 2013 Dec;30(10):879-902. doi: 10.1016/j.rmr.2013.09.007. Epub 2013 Oct 25. No abstract available. Erratum In: Rev Mal Respir. 2014 Feb;31(2):194-5. French.
PMID: 24314711
citation: Raghu G, Collard HR, Egan JJ, Martinez FJ, Behr J, Brown KK, Colby TV, Cordier JF, Flaherty KR, Lasky JA, Lynch DA, Ryu JH, Swigris JJ, Wells AU, Ancochea J, Bouros D, Carvalho C, Costabel U, Ebina M, Hansell DM, Johkoh T, Kim DS, King TE Jr, Kondoh Y, Myers J, Muller NL, Nicholson AG, Richeldi L, Selman M, Dudden RF, Griss BS, Protzko SL, Schunemann HJ; ATS/ERS/JRS/ALAT Committee on Idiopathic Pulmonary Fibrosis. An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. Am J Respir Crit Care Med. 2011 Mar 15;183(6):788-824. doi: 10.1164/rccm.2009-040GL.
PMID: 21471066
citation: Nalysnyk L, Cid-Ruzafa J, Rotella P, Esser D. Incidence and prevalence of idiopathic pulmonary fibrosis: review of the literature. Eur Respir Rev. 2012 Dec 1;21(126):355-61. doi: 10.1183/09059180.00002512.
PMID: 23204124
citation: Huang XF, Gao F, Xue ZQ, Wang Y, Xu GW. [Multifactorial analysis of survival in breast cancer]. Zhonghua Zhong Liu Za Zhi. 1988 Mar;10(2):117-9. Chinese.
PMID: 3208648
citation: du Bois RM, Weycker D, Albera C, Bradford WZ, Costabel U, Kartashov A, Lancaster L, Noble PW, Sahn SA, Szwarcberg J, Thomeer M, Valeyre D, King TE Jr. Six-minute-walk test in idiopathic pulmonary fibrosis: test validation and minimal clinically important difference. Am J Respir Crit Care Med. 2011 May 1;183(9):1231-7. doi: 10.1164/rccm.201007-1179OC. Epub 2010 Dec 3.
PMID: 21131468
citation: Nathan SD, du Bois RM, Albera C, Bradford WZ, Costabel U, Kartashov A, Noble PW, Sahn SA, Valeyre D, Weycker D, King TE Jr. Validation of test performance characteristics and minimal clinically important difference of the 6-minute walk test in patients with idiopathic pulmonary fibrosis. Respir Med. 2015 Jul;109(7):914-22. doi: 10.1016/j.rmed.2015.04.008. Epub 2015 Apr 24.
PMID: 25956020
citation: ATS Committee on Proficiency Standards for Clinical Pulmonary Function Laboratories. ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med. 2002 Jul 1;166(1):111-7. doi: 10.1164/ajrccm.166.1.at1102. No abstract available. Erratum In: Am J Respir Crit Care Med. 2016 May 15;193(10):1185.
PMID: 12091180
citation: Jones CJ, Rikli RE, Beam WC. A 30-s chair-stand test as a measure of lower body strength in community-residing older adults. Res Q Exerc Sport. 1999 Jun;70(2):113-9. doi: 10.1080/02701367.1999.10608028.
PMID: 10380242
citation: Buatois S, Miljkovic D, Manckoundia P, Gueguen R, Miget P, Vancon G, Perrin P, Benetos A. Five times sit to stand test is a predictor of recurrent falls in healthy community-living subjects aged 65 and older. J Am Geriatr Soc. 2008 Aug;56(8):1575-7. doi: 10.1111/j.1532-5415.2008.01777.x. No abstract available.
PMID: 18808608
citation: Macfarlane DJ, Chou KL, Cheng YH, Chi I. Validity and normative data for thirty-second chair stand test in elderly community-dwelling Hong Kong Chinese. Am J Hum Biol. 2006 May-Jun;18(3):418-21. doi: 10.1002/ajhb.20503.
PMID: 16634026
citation: Hill CJ, Denehy L, Holland AE, McDonald CF. Measurement of functional activity in chronic obstructive pulmonary disease: the grocery shelving task. J Cardiopulm Rehabil Prev. 2008 Nov-Dec;28(6):402-9. doi: 10.1097/HCR.0b013e31818c3c65.
PMID: 19008696
citation: Perrault H, Baril J, Henophy S, Rycroft A, Bourbeau J, Maltais F. Paced-walk and step tests to assess exertional dyspnea in COPD. COPD. 2009 Oct;6(5):330-9. doi: 10.1080/15412550903156317.
PMID: 19863362
citation: Brodin E, Ljungman S, Sunnerhagen KS. Rising from a chair: a simple screening test for physical function in predialysis patients. Scand J Urol Nephrol. 2008;42(3):293-300. doi: 10.1080/00365590701797556.
PMID: 18432536
citation: Ozalevli S, Ozden A, Itil O, Akkoclu A. Comparison of the Sit-to-Stand Test with 6 min walk test in patients with chronic obstructive pulmonary disease. Respir Med. 2007 Feb;101(2):286-93. doi: 10.1016/j.rmed.2006.05.007. Epub 2006 Jun 27.
PMID: 16806873
citation: Craig CP, Reynolds SL, Airhart JW, Staab EV. Alterations in immune responses by attenuated Venezuelan equine encephalitis vaccine. I. Adjuvant effect of VEE virus infection in guinea pigs. J Immunol. 1969 May;102(5):1220-7. No abstract available.
PMID: 4181548
citation: Bland JM, Altman DG. Measuring agreement in method comparison studies. Stat Methods Med Res. 1999 Jun;8(2):135-60. doi: 10.1177/096228029900800204.
PMID: 10501650
citation: Passing H, Bablok. A new biometrical procedure for testing the equality of measurements from two different analytical methods. Application of linear regression procedures for method comparison studies in clinical chemistry, Part I. J Clin Chem Clin Biochem. 1983 Nov;21(11):709-20. doi: 10.1515/cclm.1983.21.11.709.
PMID: 6655447
citation: Carstensen B. Comparing methods of measurement: Extending the LoA by regression. Stat Med. 2010 Feb 10;29(3):401-10. doi: 10.1002/sim.3769.
PMID: 19998394
responsible party type: Sponsor
mesh term: Pulmonary Fibrosis
mesh term: Idiopathic Pulmonary Fibrosis
mesh term: Fibrosis
sharing ipd: Undecided